Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through ...
Mesquite, NV — Dogecoin Cash Inc. (OTCQB:DOGP) today announced that its Board of Directors has approved a special distribution of DogeCoin Cash (MEMECOIN:DOG) to shareholders of record as of December ...
Approved by the European Commission in May 2025 with a total budget of €13.6 million, PREDI-LYNCH is a six-year (2025–2031) Horizon Europe initiative coordinated by Oslo University Hospital (OUS) and ...
A digital version of the presentation can be found on the Publications section of the Upstream Bio website.
LONDON, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Pulselight, a data analytics company that has developed software AI products capable of transforming the UK health system, today announces the appointment of ...
Long-term antibody persistence is a key competitive advantage for a vaccine targeting unpredictable outbreak diseases like chikungunya ...
Basel, 30 September 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the primary results from the TSIX Study Program, which evaluated the performance of its new sixth-generation high-sensitivity ...
Invested in Stalicla SA, confirming commitment to advancing innovative treatments for CNS disorders ...
MagnetOs MIS sets a new standard in minimally invasive surgery as the only bone graft delivery system that is sterile, prefilled, free of human tissue, and with a mechanism of action backed by Level I ...
SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced it will ...
The webcast presentation will take place at 5:00 p.m. ET on Tuesday, September 30, 2025. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/fall2025/ or ...
Upon completion, Biopharma Co will be a clinical-stage biotechnology company focused on the development and potential commercialization of innovative therapeutics for autoimmune and inflammatory ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback